IFNG and neoplasm: Alizadeh D. et al. showed in a GBM model that the increased production of IFNγ by CAR T cells provides immune-stimulatory effects that changed the tumour immune landscape, including both myeloid and lymphoid compartments to promote a more activated and less suppressive TME [182].